Physician Assistant · Millinocket, ME
NPI
1760494603
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 Somerset St
Millinocket, ME, 04462
Phone (207) 723-5161
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
2,536 services
Medicare patients, 2024
547
Average age 76
Drug cost, 2024
$1.5M
1,434 prescriptions
Company payments, 2025
$1,690
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas Rhoda was code 17003 (destruction skin lesion), 1,126 times for 187 patients. In total Douglas Rhoda billed 2,536 services in 44 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,126 | 187 | $3.77 | $4,240 |
| 99213 Office E&M - Established | Office | 451 | 369 | $45.90 | $21K |
| 17000 Destruction Skin Lesion | Office | 287 | 236 | $29.25 | $8,396 |
| 17110 Destruction Skin Lesion | Office | 145 | 133 | $60.65 | $8,794 |
| 11102 Skin Biopsy | Office | 119 | 109 | $49.28 | $5,865 |
| 99214 Office E&M - Established | Office | 81 | 70 | $65.14 | $5,276 |
| 99203 Office E&M - New | Office | 69 | 69 | $53.19 | $3,670 |
| 99212 Office E&M - Established | Office | 58 | 51 | $30.66 | $1,778 |
| 17262 Destruction Skin Lesion | Office | 29 | 26 | $108.02 | $3,133 |
| 11103 Skin Biopsy | Office | 21 | 17 | $28.36 | $596 |
| 99204 Office E&M - New | Office | 19 | 19 | $77.19 | $1,467 |
| 17004 Destruction Skin Lesion | Office | 17 | 13 | $100.36 | $1,706 |
| 11200 Removal or Shaving of Skin Growth | Office | 16 | 14 | $43.84 | $701 |
| 99202 Office E&M - New | Office | 13 | 13 | $26.30 | $342 |
By year: 2022 $59K for 2,150 services; 2023 $64K for 3,365 services; 2024 $74K for 2,536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas Rhoda prescribed most often to Medicare patients was Triamcinolone Acetonide, with 168 prescriptions and refills. In total Douglas Rhoda wrote 1,434 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 168 | 212 | 126 | $1,398 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 161 | 175 | 111 | $2,494 |
| Ketoconazole Generic | 120 | 136 | 77 | $2,357 |
| Otezla Apremilast | 108 | 112 | 17 | $545K |
| Dupixent Pen Dupilumab | 94 | 100 | 11 | $376K |
| Fluorouracil Generic | 90 | 95 | 82 | $5,433 |
| Fluocinonide Generic | 84 | 99 | 65 | $3,220 |
| Doxycycline Hyclate Generic | 81 | 143 | 53 | $2,990 |
| Clobetasol Propionate Generic | 42 | 48 | 25 | $1,828 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 40 | 47 | 30 | $771 |
| Mupirocin Generic | 39 | 39 | 32 | $241 |
| Clindamycin Phosphate Generic | 28 | 39 | 17 | $1,382 |
| Metronidazole Generic | 27 | 30 | 17 | $994 |
| Calcipotriene Generic | 26 | 29 | 16 | $4,107 |
| Tacrolimus Generic | 23 | 30 | 17 | $2,470 |
Brand drugs: 321 claims; generic drugs: 1,113 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas Rhoda $1,690 ($1,690 in general payments such as food, travel and fees) from 15 companies. The largest payer was Galderma Laboratories, L.P. with $431.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 25 | $431 |
| Abbvie Inc. ABBV | 33 | $280 |
| UCB, Inc. UCB.BR | 3 | $198 |
| Janssen Biotech, Inc. JNJ | 3 | $153 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $108 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $103 |
| Amgen Inc. AMGN | 1 | $100 |
| Arcutis Biotherapeutics, Inc. ARQT | 1 | $83.38 |
| LEO Pharma Inc. | 2 | $69.72 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $55.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.